SIAH2 and breast carcinoma: Thus, expression of SIAH2 in DDLPS tumor-associated macrophage and other stromal cells indicates SIAH2 expression may serve as a molecular marker distinguishing between DDLPS and WDLPS as well as a therapeutic target in DDLPS similar to melanoma, prostate, and breast cancer [56–58].